664 related articles for article (PubMed ID: 33711555)
1. Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist.
Grunddal KV; Diep TA; Petersen N; Tough IR; Skov LJ; Liu L; Buijink JA; Mende F; Jin C; Jepsen SL; Sørensen LME; Achiam MP; Strandby RB; Bach A; Hartmann B; Frimurer TM; Hjorth SA; Bouvier M; Cox H; Holst B
Mol Metab; 2021 Jul; 49():101207. PubMed ID: 33711555
[TBL] [Abstract][Full Text] [Related]
2. Gut hormones as peripheral anti obesity targets.
Small CJ; Bloom SR
Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
[TBL] [Abstract][Full Text] [Related]
3. L-arginine promotes gut hormone release and reduces food intake in rodents.
Alamshah A; McGavigan AK; Spreckley E; Kinsey-Jones JS; Amin A; Tough IR; O'Hara HC; Moolla A; Banks K; France R; Hyberg G; Norton M; Cheong W; Lehmann A; Bloom SR; Cox HM; Murphy KG
Diabetes Obes Metab; 2016 May; 18(5):508-18. PubMed ID: 26863991
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Enteroendocrine System for Treatment of Obesity.
Miedzybrodzka EL; Gribble FM; Reimann F
Handb Exp Pharmacol; 2022; 274():487-513. PubMed ID: 35419620
[TBL] [Abstract][Full Text] [Related]
5. Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells.
Billing LJ; Smith CA; Larraufie P; Goldspink DA; Galvin S; Kay RG; Howe JD; Walker R; Pruna M; Glass L; Pais R; Gribble FM; Reimann F
Mol Metab; 2018 Oct; 16():65-75. PubMed ID: 30104166
[TBL] [Abstract][Full Text] [Related]
6. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY.
Chandarana K; Gelegen C; Karra E; Choudhury AI; Drew ME; Fauveau V; Viollet B; Andreelli F; Withers DJ; Batterham RL
Diabetes; 2011 Mar; 60(3):810-8. PubMed ID: 21292870
[TBL] [Abstract][Full Text] [Related]
7. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents.
Psichas A; Sleeth ML; Murphy KG; Brooks L; Bewick GA; Hanyaloglu AC; Ghatei MA; Bloom SR; Frost G
Int J Obes (Lond); 2015 Mar; 39(3):424-9. PubMed ID: 25109781
[TBL] [Abstract][Full Text] [Related]
8. Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas.
Kuhre RE; Wewer Albrechtsen NJ; Larsen O; Jepsen SL; Balk-Møller E; Andersen DB; Deacon CF; Schoonjans K; Reimann F; Gribble FM; Albrechtsen R; Hartmann B; Rosenkilde MM; Holst JJ
Mol Metab; 2018 May; 11():84-95. PubMed ID: 29656109
[TBL] [Abstract][Full Text] [Related]
9. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR
Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744
[TBL] [Abstract][Full Text] [Related]
10. Impact of TOTUM-63, a fibre and polyphenol rich plant-based composition, on gut and pancreatic hormone secretion in diet-induced obese mice.
Chavanelle V; Chanon S; Pinteur C; Loizon E; Vial G; Otero YF; Le Joubioux F; Maugard T; Peltier SL; Sirvent P; Morio B
Nutr Metab Cardiovasc Dis; 2022 Jul; 32(7):1797-1807. PubMed ID: 35618560
[TBL] [Abstract][Full Text] [Related]
11. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
Rohde U
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
[TBL] [Abstract][Full Text] [Related]
12. l-phenylalanine modulates gut hormone release and glucose tolerance, and suppresses food intake through the calcium-sensing receptor in rodents.
Alamshah A; Spreckley E; Norton M; Kinsey-Jones JS; Amin A; Ramgulam A; Cao Y; Johnson R; Saleh K; Akalestou E; Malik Z; Gonzalez-Abuin N; Jomard A; Amarsi R; Moolla A; Sargent PR; Gray GW; Bloom SR; Murphy KG
Int J Obes (Lond); 2017 Nov; 41(11):1693-1701. PubMed ID: 28792489
[TBL] [Abstract][Full Text] [Related]
13. Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.
Ullmer C; Alvarez Sanchez R; Sprecher U; Raab S; Mattei P; Dehmlow H; Sewing S; Iglesias A; Beauchamp J; Conde-Knape K
Br J Pharmacol; 2013 Jun; 169(3):671-84. PubMed ID: 23488746
[TBL] [Abstract][Full Text] [Related]
14. A Gut-Intrinsic Melanocortin Signaling Complex Augments L-Cell Secretion in Humans.
Sun EW; Iepsen EW; Pezos N; Lumsden AL; Martin AM; Schober G; Isaacs NJ; Rayner CK; Nguyen NQ; de Fontgalland D; Rabbitt P; Hollington P; Wattchow DA; Hansen T; Holm JC; Liou AP; Jackson VM; Torekov SS; Young RL; Keating DJ
Gastroenterology; 2021 Aug; 161(2):536-547.e2. PubMed ID: 33848536
[TBL] [Abstract][Full Text] [Related]
15. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
[TBL] [Abstract][Full Text] [Related]
16. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
[TBL] [Abstract][Full Text] [Related]
17. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
[TBL] [Abstract][Full Text] [Related]
18. The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans.
Mandøe MJ; Hansen KB; Hartmann B; Rehfeld JF; Holst JJ; Hansen HS
Am J Clin Nutr; 2015 Sep; 102(3):548-55. PubMed ID: 26178726
[TBL] [Abstract][Full Text] [Related]
19. Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models.
Forbes S; Stafford S; Coope G; Heffron H; Real K; Newman R; Davenport R; Barnes M; Grosse J; Cox H
Diabetes; 2015 Nov; 64(11):3763-71. PubMed ID: 26239054
[TBL] [Abstract][Full Text] [Related]
20. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
